1. Cancer Biology
  2. Cell Biology

Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties

  1. Delphine Fessart  Is a corresponding author
  2. Charlotte Domblides
  3. Tony Avril
  4. Leif A Eriksson
  5. Hugues Begueret
  6. Raphael Pineau
  7. Camille Malrieux
  8. Nathalie Dugot-Senant
  9. Carlo Lucchesi
  10. Eric Chevet
  11. Frederic Delom
  1. Université de Bordeaux, France
  2. University of Rennes 1, France
  3. University of Gothenburg, Sweden
  4. Hôpital Haut-Lévêque, France
  5. Bergonié Cancer Institute, France
https://doi.org/10.7554/eLife.13887
Share this article
Cite this article
  1. Delphine Fessart
  2. Charlotte Domblides
  3. Tony Avril
  4. Leif A Eriksson
  5. Hugues Begueret
  6. Raphael Pineau
  7. Camille Malrieux
  8. Nathalie Dugot-Senant
  9. Carlo Lucchesi
  10. Eric Chevet
  11. Frederic Delom
(2016)
Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties
eLife 5:e13887.
https://doi.org/10.7554/eLife.13887
  2. Download BibTeX
  3. Download .RIS

Abstract

The extracellular matrix (ECM) plays an instrumental role in determining the spatial orientation of epithelial polarity and the formation of lumens in glandular tissues during morphogenesis. Here, we show that the Endoplasmic Reticulum (ER)-resident protein anterior gradient-2 (AGR2), a soluble protein-disulfide isomerase involved in ER protein folding and quality control, is secreted and interacts with the ECM. Extracellular AGR2 (eAGR2) is a microenvironmental regulator of epithelial tissue architecture, which plays a role in the preneoplastic phenotype and contributes to epithelial tumorigenicity. Indeed, eAGR2, is secreted as a functionally active protein independently of its thioredoxin-like domain (CXXS) and of its ER-retention domain (KTEL), and is sufficient, by itself, to promote the acquisition of invasive and metastatic features. Therefore, we conclude that eAGR2 plays an extracellular role independent of its ER function and we elucidate this gain-of-function as a novel and unexpected critical ECM microenvironmental pro-oncogenic regulator of epithelial morphogenesis and tumorigenesis.

Article and author information

Author details

  1. Delphine Fessart

    Université de Bordeaux, Bordeaux, France
    For correspondence
    delphine.fessart@yahoo.fr
    Competing interests
    The authors declare that no competing interests exist.

  2. Charlotte Domblides

    Université de Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  3. Tony Avril

    Oncogenesis, Stress, Signaling, University of Rennes 1, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.

  4. Leif A Eriksson

    Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  5. Hugues Begueret

    Hôpital Haut-Lévêque, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  6. Raphael Pineau

    Université de Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  7. Camille Malrieux

    Université de Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  8. Nathalie Dugot-Senant

    Université de Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  9. Carlo Lucchesi

    Bergonié Cancer Institute, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  10. Eric Chevet

    Oncogenesis, Stress, Signaling, University of Rennes 1, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.

  11. Frederic Delom

    Université de Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Johanna Ivaska, University of Turku, Finland

Ethics

Animal experimentation: All animal procedures met the European Community Directive guidelines (Agreement B33-522-2/ Number DIR 1322) and were approved by the ethical committee from Bordeaux University.

Human subjects: Samples of human lung cancer tissues were obtained from the Haut-Leveque University Hospital (Bordeaux, France) and reviewed by expert pathologist in the field (H. Begueret). These procedures were approved by the Institutional Review Board at Haut-Leveque (NFS96900 Certification).

Version history

  1. Received: December 17, 2015
  2. Accepted: May 28, 2016
  3. Accepted Manuscript published: May 30, 2016 (version 1)
  4. Version of Record published: July 11, 2016 (version 2)

Copyright

© 2016, Fessart et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,158
    views
  • 1,247
    downloads
  • 66
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Delphine Fessart
  2. Charlotte Domblides
  3. Tony Avril
  4. Leif A Eriksson
  5. Hugues Begueret
  6. Raphael Pineau
  7. Camille Malrieux
  8. Nathalie Dugot-Senant
  9. Carlo Lucchesi
  10. Eric Chevet
  11. Frederic Delom
(2016)
Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties
eLife 5:e13887.
https://doi.org/10.7554/eLife.13887

Share this article

https://doi.org/10.7554/eLife.13887

Categories and tags

Research organisms

Further reading

    1. Cancer Biology
    2. Cell Biology

    A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo

    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology

    Cancer: Modeling glioblastoma

    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.

    1. Cancer Biology

    YAP/TAZ enhances P-body formation to promote tumorigenesis

    Xia Shen, Xiang Peng ... Chen-Ying Liu
    Research Article

    The role of processing bodies (P-bodies) in tumorigenesis and tumor progression is not well understood. Here, we showed that the oncogenes YAP/TAZ promote P-body formation in a series of cancer cell lines. Mechanistically, both transcriptional activation of the P-body-related genes SAMD4A, AJUBA, and WTIP and transcriptional suppression of the tumor suppressor gene PNRC1 are involved in enhancing the effects of YAP/TAZ on P-body formation in colorectal cancer (CRC) cells. By reexpression of PNRC1 or knockdown of P-body core genes (DDX6, DCP1A, and LSM14A), we determined that disruption of P-bodies attenuates cell proliferation, cell migration, and tumor growth induced by overexpression of YAP5SA in CRC. Analysis of a pancancer CRISPR screen database (DepMap) revealed co-dependencies between YAP/TEAD and the P-body core genes and correlations between the mRNA levels of SAMD4A, AJUBA, WTIP, PNRC1, and YAP target genes. Our study suggests that the P-body is a new downstream effector of YAP/TAZ, which implies that reexpression of PNRC1 or disruption of P-bodies is a potential therapeutic strategy for tumors with active YAP.